These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22289872)

  • 1. Gastric acid suppression and Clostridium difficile infection: is there a causal connection?
    Khanna S; Pardi DS
    Clin Gastroenterol Hepatol; 2012 May; 10(5):564; author reply 564. PubMed ID: 22289872
    [No Abstract]   [Full Text] [Related]  

  • 2. The importance of quality appraisal in meta-analysis.
    Mahady SE; Webster AC
    Clin Gastroenterol Hepatol; 2012 Sep; 10(9):1057; author reply 1057-8. PubMed ID: 22503999
    [No Abstract]   [Full Text] [Related]  

  • 3. Clostridium difficile infection: managing the risks.
    DeDea L
    JAAPA; 2012 May; 25(5):16. PubMed ID: 22712142
    [No Abstract]   [Full Text] [Related]  

  • 4. Clostridium difficile infection and proton pump inhibitors.
    Pohl JF
    Curr Opin Pediatr; 2012 Oct; 24(5):627-31. PubMed ID: 22781139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of Clostridium difficile infections in patients receiving antimicrobial and acid-suppression therapy.
    King RN; Lager SL
    Pharmacotherapy; 2011 Jul; 31(7):642-8. PubMed ID: 21923450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between proton pump inhibitor therapy and Clostridium difficile infection in a meta-analysis.
    Deshpande A; Pant C; Pasupuleti V; Rolston DD; Jain A; Deshpande N; Thota P; Sferra TJ; Hernandez AV
    Clin Gastroenterol Hepatol; 2012 Mar; 10(3):225-33. PubMed ID: 22019794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clostridium difficile.
    Baierlein SA; Wistop A
    N Engl J Med; 2009 Feb; 360(6):636-7; author reply 637-8. PubMed ID: 19202581
    [No Abstract]   [Full Text] [Related]  

  • 8. Proton pump inhibitors and risk of Clostridium difficile infection: a multi-country study using sequence symmetry analysis.
    Roughead EE; Chan EW; Choi NK; Griffiths J; Jin XM; Lee J; Kimura M; Kimura T; Kubota K; Lai EC; Man KK; Nguyen TA; Ooba N; Park BJ; Sato T; Shin JY; Wang T; Wong IC; Yang YK; Pratt NL
    Expert Opin Drug Saf; 2016 Dec; 15(12):1589-1595. PubMed ID: 27645304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re: proton pump inhibitors and risk for recurrent Clostridium difficile infection among inpatients.
    Abdallah J; Hassan T; Kyprianou A
    Am J Gastroenterol; 2014 Apr; 109(4):601-2. PubMed ID: 24698870
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluating the Risk Factors for Hospital-Onset Clostridium difficile Infections in a Large Healthcare System.
    Watson T; Hickok J; Fraker S; Korwek K; Poland RE; Septimus E
    Clin Infect Dis; 2018 Jun; 66(12):1957-1959. PubMed ID: 29272341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton Pump Inhibitors Should be Used with Caution in Critically Ill Patients to Prevent the Risk of Clostridium difficile Infection.
    Min JH; Kim YS
    Gut Liver; 2016 Jul; 10(4):493-4. PubMed ID: 27377737
    [No Abstract]   [Full Text] [Related]  

  • 12. Clostridium difficile infection and colonization.
    Lapane KL; Motzkus-Feagans C; Pakyz A
    N Engl J Med; 2012 Jan; 366(3):276; author reply 276-7. PubMed ID: 22256813
    [No Abstract]   [Full Text] [Related]  

  • 13. A case-control study of community-associated Clostridium difficile infection: no role for proton pump inhibitors.
    Naggie S; Miller BA; Zuzak KB; Pence BW; Mayo AJ; Nicholson BP; Kutty PK; McDonald LC; Woods CW
    Am J Med; 2011 Mar; 124(3):276.e1-7. PubMed ID: 21396512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of Proton Pump Inhibitors and Risk of Nosocomial Clostridium Difficile Infection in Hospitalized Elderly Adults.
    Depoorter L; Verhaegen J; Joosten E
    J Am Geriatr Soc; 2016 Mar; 64(3):667-9. PubMed ID: 27000353
    [No Abstract]   [Full Text] [Related]  

  • 15. Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection.
    Howell MD; Novack V; Grgurich P; Soulliard D; Novack L; Pencina M; Talmor D
    Arch Intern Med; 2010 May; 170(9):784-90. PubMed ID: 20458086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton pump inhibitors are an independent risk factor for an increased length of hospital stay in patients with Clostridium difficile infection.
    Nachnani JS; Bulchandani D; Allen MJ
    Indian J Gastroenterol; 2008; 27(4):171-2. PubMed ID: 18974472
    [No Abstract]   [Full Text] [Related]  

  • 17. Proton pump inhibitors and diarrhoea related to Clostridium difficile infection in hospitalised patients: a case-control study.
    Leonard AD; Ho KM; Flexman J
    Intern Med J; 2012 May; 42(5):591-4. PubMed ID: 22616966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for Clostridium difficile-associated diarrhea among hospitalized adults with fecal toxigenic C. difficile colonization.
    Lin HJ; Hung YP; Liu HC; Lee JC; Lee CI; Wu YH; Tsai PJ; Ko WC
    J Microbiol Immunol Infect; 2015 Apr; 48(2):183-9. PubMed ID: 24064285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Acid Suppression Medication is Associated With Risk for C. difficile Infection in Infants and Children: A Population-based Study.
    Freedberg DE; Lamousé-Smith ES; Lightdale JR; Jin Z; Yang YX; Abrams JA
    Clin Infect Dis; 2015 Sep; 61(6):912-7. PubMed ID: 26060292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of Clostridium difficile infection in patients receiving high-risk antibiotics with or without a proton pump inhibitor.
    Gordon D; Young LR; Reddy S; Bergman C; Young JD
    J Hosp Infect; 2016 Feb; 92(2):173-7. PubMed ID: 26616410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.